RPG Life Sciences Limited — Updates, 28-07-2026: Press Release
28-07-2026 | 08:11 pm
28-07-2026 | 08:11 pm
RPG Life Sciences reported strong Q1 FY27 results: Revenue up 15.8% to ₹195.7 Cr, EBITDA up 17.9% to ₹48.0 Cr, with EBITDA margins at 24.5%. Domestic Formulations grew 14.8%, outperforming the market, entering the Top 50 Indian Pharma Companies.
No comments yet. Be the first to comment!
